Company Filing History:
Years Active: 1995-1996
Title: Subramaniam Krishnananthan: Innovator in Pharmaceutical Compounds
Introduction
Subramaniam Krishnananthan is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that address various medical conditions. With a total of 2 patents, his work is recognized for its potential impact on healthcare.
Latest Patents
Krishnananthan's latest patents include innovative compounds such as substituted tryptamines and phenalkylamines. The first patent focuses on novel substituted tryptamine and phenalkylamine compounds, along with their pharmaceutical compositions and methods of use. The second patent expands on this by detailing the applications of these compounds for a range of pharmaceutical indications. These indications include central nervous system and psychiatric disorders, chronobiological-based disorders, endocrine indications, cancer, immune system disorders, ophthalmological diseases, and even applications in animal breeding.
Career Highlights
Currently, Subramaniam Krishnananthan is associated with Interneuron Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing solutions for complex medical challenges.
Collaborations
Throughout his career, Krishnananthan has collaborated with esteemed colleagues such as Kay Jorgenson D'Orlando and Kenneth W Locke. These partnerships have further enriched his research and development efforts.
Conclusion
Subramaniam Krishnananthan stands out as a significant figure in the realm of pharmaceutical innovations. His contributions through patents and collaborations highlight his dedication to advancing medical science and improving patient outcomes.